Overview
Eosinophilic esophagitis, often called EoE for short, is a chronic condition where a type of white blood cell called an eosinophil builds up in the esophagus — the tube that carries food from your mouth to your stomach. Normally, eosinophils are not found in the esophagus, but in EoE they gather there and cause inflammation, which makes swallowing difficult and painful over time. EoE is considered an allergic or immune-driven disease, and it is closely linked to food allergies and environmental allergies like pollen. The most common symptoms include trouble swallowing solid foods, food getting stuck in the throat or chest, heartburn that does not respond well to standard acid-reducing medicines, chest pain, and in children, poor growth or refusal to eat. Symptoms can vary a lot between children and adults. Children may show up as picky eaters or have poor weight gain, while adults more often notice food getting stuck. Treatment focuses on reducing inflammation and managing triggers. The main approaches include dietary changes (removing common food allergens like milk, wheat, eggs, soy, nuts, and seafood), swallowed corticosteroid medications (like budesonide or fluticasone), and proton pump inhibitors (acid-reducing drugs). In 2022, the FDA approved dupilumab (Dupixent) as the first biologic drug specifically for EoE in adults and adolescents. Endoscopic dilation may be needed if the esophagus has narrowed. With proper management, most people with EoE can live well, though the condition is usually lifelong.
Also known as:
Key symptoms:
Difficulty swallowing, especially solid foodsFood getting stuck in the throat or chest (food impaction)Heartburn or chest pain that does not improve with standard antacidsNausea or vomitingAbdominal painRegurgitation of foodRefusing to eat or being a very picky eater (especially in children)Poor weight gain or growth problems in childrenFeeling full very quicklyThroat tightness or discomfortCoughing or gagging during mealsNeeding to drink lots of water to wash food down
Multifactorial
Caused by a mix of several genes and environmental factors
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
10 eventsDUPIXENT: New indication approved
Mayo Clinic — EARLY_PHASE1
Kate Farms Inc — NA
Regeneron Pharmaceuticals — PHASE3
Sheba Medical Center — NA
University Hospital, Angers
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
2 availableEohilia
treatment for 12 weeks in adult and pediatric patients 11 years of age and older with eosinophilic esophagitis (EoE)
Dupixent
Treatment of adult and pediatric patients aged 12 years and older, weighing at least 40 kg, with eosinophilic esophagitis (EoE)
Specialists
View all specialists →No specialists are currently listed for NON RARE IN EUROPE: Eosinophilic esophagitis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
2 resourcesTravel Grants
No travel grants are currently matched to NON RARE IN EUROPE: Eosinophilic esophagitis.
Community
No community posts yet. Be the first to share your experience with NON RARE IN EUROPE: Eosinophilic esophagitis.
Start the conversation →Latest news about NON RARE IN EUROPE: Eosinophilic esophagitis
No recent news articles for NON RARE IN EUROPE: Eosinophilic esophagitis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the best treatment approach for my specific case — diet, medication, or both?,How often will I need endoscopies to monitor my condition?,Should I see an allergist to identify my food or environmental triggers?,Am I a candidate for dupilumab (Dupixent), and what are the pros and cons?,What are the signs that my esophagus is narrowing, and when would I need a dilation procedure?,How do I safely follow an elimination diet without missing important nutrients?,What should I do if food gets completely stuck and I cannot swallow?
Common questions about NON RARE IN EUROPE: Eosinophilic esophagitis
What is NON RARE IN EUROPE: Eosinophilic esophagitis?
Eosinophilic esophagitis, often called EoE for short, is a chronic condition where a type of white blood cell called an eosinophil builds up in the esophagus — the tube that carries food from your mouth to your stomach. Normally, eosinophils are not found in the esophagus, but in EoE they gather there and cause inflammation, which makes swallowing difficult and painful over time. EoE is considered an allergic or immune-driven disease, and it is closely linked to food allergies and environmental allergies like pollen. The most common symptoms include trouble swallowing solid foods, food gettin
How is NON RARE IN EUROPE: Eosinophilic esophagitis inherited?
NON RARE IN EUROPE: Eosinophilic esophagitis follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Are there clinical trials for NON RARE IN EUROPE: Eosinophilic esophagitis?
Yes — 18 recruiting clinical trials are currently listed for NON RARE IN EUROPE: Eosinophilic esophagitis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
What treatment and support options exist for NON RARE IN EUROPE: Eosinophilic esophagitis?
2 patient support programs are currently tracked on UniteRare for NON RARE IN EUROPE: Eosinophilic esophagitis. See the treatments and support programs sections for copay assistance, eligibility, and contact details.